drugset / Trial / NCT01081782
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to evaluate the safety and efficacy of ONO-4641 in patients with relapsing-remitting multiple sclerosis over a 26-week treatment period.
Timeline
- Start
- 2010-03
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ONO-4641 | Unknown | 0.05 mg | — |
| Subject | ONO-4641 | Unknown | 0.1 mg | — |
| Subject | ONO-4641 | Unknown | 0.15 mg | — |